MORAb-202, an Antibody-Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity
Cheng, Xin, Li, Jing, Tanaka, Keigo, Majumder, Utpal, Milinichik, Andrew Z, Verdi, Arielle C, Maddage, Christopher J, Rybinski, Katherine A, Fernando, Shawn, Fernando, Danielle, Kuc, Megan, Furuuchi, Keiji, Fang, Frank, Uenaka, Toshimitsu, Grasso, Luigi, Albone, Earl F
Published in Molecular cancer therapeutics (01.12.2018)
Published in Molecular cancer therapeutics (01.12.2018)
Get full text
Journal Article